evaluated the category II algorithm by Clark et al. Women laboring and/or undergoing induction at 37 weeks gestation were included. Cases were defined by base deficit (BD) in excess of -12 mM/L. Two controls with BD smaller than -8 mM/L were matched to each case for parity, year, and gestational age. Maternal demographic, obstetric, and medical data was collected. For both cases and controls, electronic fetal heart rate monitoring was reviewed to determine (1) if the category II algorithm recommended expedited delivery and (2) time to delivery if expedited delivery was indicated. Odds ratios (OR) were calculated with 95% confidence intervals (CI) as measures of effect. RESULTS: 44 cases and 88 matched controls were identified. Cases were most likely to have Medicaid insurance, to be delivered by cesarean section, and to be delivered for non-reassuring fetal heart tracing patterns (Table) . In 68% of cases the category algorithm II recommended expedited delivery. In comparison, expedited delivery was recommended in 10% of controls. The OR for cases compared to controls was statistically significant (OR 16.77, 95% CI 5.09 to 55.33). In cases where expedited delivery was recommended, 42% occurred during the latent phase of labor. In evaluating time to delivery after expedited delivery was recommended by the category II algorithm, in 41% of cases delivery was made in <30 minutes, 32% of patients delivered 31 to 90 minutes, and 27% delivered at >90 minutes ( Figure) . CONCLUSION: Recommendation for expedited delivery by the category II algorithm is associated with increased risk for severe neonatal acidemia. In the majority of cases in this case-control study, delivery occurred after 30 minutes suggesting that neonatal outcomes may be improved by adherence to algorithm recommendations.
771 Neonatal morbi-mortality and planned mode of delivery in twin pregnancies with breech presenting first twins OBJECTIVE: To evaluate the association between the planned mode of delivery and neonatal mortality and morbidity in twin pregnancies with a first twin in breech presentation STUDY DESIGN: In this planned secondary analysis of the JUMODA cohort, a national prospective population-based study of twin deliveries conducted from 02/2014 to 03/2015 in 176 hospitals in France, we included women with twin pregnancies and their neonates born alive at or after 32 weeks of gestation if the first twin was in breech presentation. Women with recognized counter indication to planned vaginal delivery (placenta or myoma previa (n¼14), previous repeated cesareans (n¼59), abnormal pelvimetry (n¼44) or monoamniotic twin pregnancy (n¼2)) were excluded. Analysis was performed according to the planned mode of delivery, planned vaginal or planned cesarean delivery (reference group). The primary Poster Session IV outcome was a composite of neonatal mortality and morbidity. Multivariate Poisson regression models were used to control for potential confounders (parity and previous cesarean, pregnancy complications, gestational age at delivery, induction of labor, 2 nd twin larger than 1 st twin, second twin presentation, annual number of twin deliveries). Associations were first estimated for both twins and then for each twin taken separately. Secondary analyses were performed after selection of a low-risk population by application of the selection criteria of the Twin Birth Study. RESULTS: Among the 1,645 twin pregnancies with the first twin in breech presentation included in this analysis, 1,311 (79.7%) had planned cesarean and 334 (20.3%) planned vaginal delivery, of whom 209 (62.6%) delivered both twins vaginally. No significant association was found between the planned mode of delivery and severe neonatal mortality and morbidity for both twins (2.7% (18/ 668) in the planned vaginal delivery group versus 3.1% (81/2622) in the planned cesarean delivery group; aRR 0.68, 95% CI 0.37-1.25), for the first twin (1.8% (6/334) versus 2.7% (36/1311), aRR 0.56 95% CI 0.21-1.47) or for the second twin (3.6% (12/334) versus 3.4% (45/1311), aRR 0.82 95% CI 0.41 -1.64). Secondary analyses yielded similar results. CONCLUSION: Compared to planned cesarean delivery, planned vaginal delivery was not associated with increased neonatal mortality and morbidity in twin pregnancies with a first twin in breech presentation. , Fergal D. Malone OBJECTIVE: In contemporary obstetric practice over 25% of women will undergo induction of labor. Although a medical intervention, induction is increasingly seen as a reasonable option for term, nulliparous women. Previously reported increases in cesarean delivery have been refuted, with clear evidence of reduced stillbirth rates. Oxytocin is the most commonly used agent; however, the optimum dosing regimen has yet to be reliably quantified. We aimed to establish the differences, if any, between low and high-dose oxytocin regimens for induction with regard to; duration of labor, mode of delivery and evidence of fetal compromise. STUDY DESIGN: This is a secondary analysis of a prospective, observational cohort e the Genesis study, where nulliparous women with a vertex presentation between 39+0 and 40+6 weeks' gestation were recruited at seven academic medical centers. All were suitable for a trial of labor at recruitment. This analysis focuses on the outcomes for women induced with oxytocin. Data in relation to oxytocin use were collected prospectively. Each study center was classified as lowdose (group 1. e 1 milliunit per minute increasing every 30 minutes) or high-dose (group 2. e 5 milliunits per minute increasing every 15 minutes). The analysis compares the outcomes for women and infants in the low and high-dose groups. RESULTS: Of the 2,336 women recruited, 563 had their labor induced with oxytocin. 277 (group 1.) were induced with a low-dose and 286 (group 2.) with a high-dose. Results for both primary and secondary outcomes are demonstrated in Table 1 . The duration of labor was similar in both groups. Operative vaginal delivery was significantly more likely in the low-dose group (p¼0.019), as was malposition. Cesarean delivery rates were higher in group 2, although this did not reach statistical significance (p¼0.108). There was no difference between the groups with regard to infant outcomes, however, a nonreassuring CTG was significantly more likely in group 2 (p¼<0.001), and fever was more frequent (p¼0.029). CONCLUSION: High-dose oxytocin did not shorten the duration of labor or increase the spontaneous vaginal delivery rate; it was associated with an increase in fever and non-reassuring CTG. The low-dose regimen saw an increase in malposition and operative vaginal delivery with its attendant potential morbidity. Neither dosing regimen can be deemed superior e an intermediate dosing regimen warrants investigation.
